Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jdi.12531 http://scihub22266oqcxt.onion/10.1111/jdi.12531 C5089956!5089956!27181090     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Diabetes+Investig 2016 ; 7 (6): 915-8 Nephropedia Template TP {{tp|p=27181090|t=2016. Fulminant type 1 diabetes mellitus with anti?programmed cell death?1 therapy |pdf=|usr=}}{{27181090}} gab.com Text Fulminant type 1 diabetes mellitus with anti programmed cell death 1 therapy JO: J Diabetes Investig http://www.kidney.de/pget.php?&tw=1&pmid=27181090 #FOAvip Anti?programmed cell death?1 (PD?1) antibodies are regarded as a risk factor for insulin?dependent diabetes mellitus as a side?effect. While a small number of cases have been reported, evidence remains limited. This is the first report of an Asian patient developing insulin?dependent diabetes during anti?PD?1 therapy. A 55?year?old euglycemic woman receiving nivolumab for malignant melanoma showed abrupt onset of ketonuria, and elevated levels of plasma glucose (580 mg/dL) and hemoglobin A1c (7.0%). Over the next 2 weeks, serum C?peptide levels fell below the limit of detection. Islet autoantibodies were negative, and the patient showed a human leukocyte antigen haplotype associated with type 1 diabetes. Anti?PD?1 therapy can cause rapid onset of insulin?dependent diabetes, possibly because of inappropriate activation of T cells. Human leukocyte antigen haplotypes might be related to the onset of this disease. Physicians should be aware of this serious adverse event and carry out routine blood glucose testing during anti?PD?1 therapy. Twit Text FOAVip Fulminant type 1 diabetes mellitus with anti programmed cell death 1 therapy ????J Diabetes Investig http://www.kidney.de/pget.php?&tw=1&pmid=27181090 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27181090 #FOAvip English Wikipedia <ref>{{Cite pmid|27181090}}</ref> Fulminant type 1 diabetes mellitus with anti?programmed cell death?1 therapy #MMPMID27181090 Okamoto M; Okamoto M; Gotoh K; Masaki T; Ozeki Y; Ando H; Anai M; Sato A; Yoshida Y; Ueda S; Kakuma T; Shibata H J Diabetes Investig 2016[Nov]; 7 (6): 915-8 PMID27181090show ga Anti?programmed cell death?1 (PD?1) antibodies are regarded as a risk factor for insulin?dependent diabetes mellitus as a side?effect. While a small number of cases have been reported, evidence remains limited. This is the first report of an Asian patient developing insulin?dependent diabetes during anti?PD?1 therapy. A 55?year?old euglycemic woman receiving nivolumab for malignant melanoma showed abrupt onset of ketonuria, and elevated levels of plasma glucose (580 mg/dL) and hemoglobin A1c (7.0%). Over the next 2 weeks, serum C?peptide levels fell below the limit of detection. Islet autoantibodies were negative, and the patient showed a human leukocyte antigen haplotype associated with type 1 diabetes. Anti?PD?1 therapy can cause rapid onset of insulin?dependent diabetes, possibly because of inappropriate activation of T cells. Human leukocyte antigen haplotypes might be related to the onset of this disease. Physicians should be aware of this serious adverse event and carry out routine blood glucose testing during anti?PD?1 therapy. äFulminant type 1 diabetes mellitus with anti?programmed cell death?1 t(epmc).pdf DeepDyve Pubget Overpricing